JPMorgan Chase & Co. Lowers Stake in Addus HomeCare Co. (NASDAQ:ADUS)

JPMorgan Chase & Co. lowered its position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 4.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 175,212 shares of the company's stock after selling 7,986 shares during the quarter. JPMorgan Chase & Co. owned about 0.97% of Addus HomeCare worth $21,963,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. State Street Corp increased its stake in Addus HomeCare by 4.4% during the 3rd quarter. State Street Corp now owns 663,610 shares of the company's stock worth $88,280,000 after acquiring an additional 27,990 shares during the period. Principal Financial Group Inc. raised its position in Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock valued at $67,293,000 after purchasing an additional 75,409 shares during the last quarter. Geode Capital Management LLC raised its holdings in Addus HomeCare by 7.1% in the 3rd quarter. Geode Capital Management LLC now owns 423,934 shares of the company's stock valued at $56,406,000 after buying an additional 28,284 shares during the last quarter. TimesSquare Capital Management LLC raised its stake in shares of Addus HomeCare by 28.5% during the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock valued at $44,593,000 after acquiring an additional 78,835 shares during the last quarter. Finally, American Century Companies Inc. lifted its holdings in Addus HomeCare by 695.8% during the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock worth $35,643,000 after buying an additional 248,613 shares during the period. Institutional investors own 95.35% of the company's stock.

Remove Ads

Addus HomeCare Price Performance

NASDAQ:ADUS traded down $0.96 on Tuesday, reaching $101.21. 23,136 shares of the company's stock were exchanged, compared to its average volume of 163,071. The firm has a market cap of $1.84 billion, a price-to-earnings ratio of 23.16, a P/E/G ratio of 1.41 and a beta of 0.93. The stock has a fifty day simple moving average of $100.73 and a 200-day simple moving average of $117.77. Addus HomeCare Co. has a 52 week low of $87.88 and a 52 week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $297.14 million for the quarter, compared to analysts' expectations of $291.04 million. As a group, sell-side analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on ADUS shares. Oppenheimer boosted their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. JMP Securities reiterated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Thursday, April 10th. Citizens Jmp upgraded shares of Addus HomeCare to a "strong-buy" rating in a report on Monday, December 16th. Stephens reissued an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday, March 12th. Finally, Macquarie reiterated an "outperform" rating and issued a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 27th. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $132.78.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.